Long‐Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European CountriesMelinda Magyari, Philippe Autier, Antoine Duclos et al.|Pharmacoepidemiology and Drug Safety|2024Cited by 3